Molecule engineering strategy of toll-like receptor 7/8 agonists designed for potentiating immune stimuli activation

Chem. Commun., 2024, Advance Article DOI: 10.1039/D4CC00792A, Feature ArticleLiuwei Gu, Xiaojie Kong, Mengyan Li, Rui Chen, Ke Xu, Guo Li, Yulin Qin, Li Wu We highlighted the recent research progress concerning the molecule engineering strategy of toll-like receptor 7/8 agonists for enhancing immunotherapy, including our research work and some related emerging works. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry

Source: RSC - Chem. Commun. latest articles - May 7, 2024 Category: Chemistry Authors: Liuwei Gu Source Type: research